The healthcare sector in the United States is at a critical juncture as private equity (PE) firms tighten their grip on hospitals, igniting fierce debate over the consequences for patient care and raising serious concerns about the balance between profit and well-being. With over $1 trillion
In a world still grappling with the aftermath of a global health crisis that recorded over 700 million cases and 7 million deaths, the role of COVID-19 vaccines stands as a testament to human ingenuity and scientific progress. These vaccines, developed at an unprecedented pace through years of
Imagine reaching for a refreshing soda on a hot day, unaware that this simple choice might play a role in accelerating a deadly disease, as recent research has spotlighted a troubling link between sugary drinks and the spread of colorectal cancer to the liver, a leading cause of mortality among
In the sprawling landscape of U.S. healthcare, a silent crisis unfolds every day as hundreds of thousands of patients suffer preventable harm or even death due to medical errors, positioning patient safety as an urgent public health challenge that demands immediate attention. With medical errors
The vaccine industry in the United States finds itself at a critical juncture, where an unprecedented level of bipartisan support offers a glimmer of hope amid swirling controversies, technological debates, and regulatory uncertainties that could shape its future trajectory. A recent poll conducted
In a landscape where millions of patients with advanced chronic kidney disease (CKD) struggle with limited and often burdensome treatment options, a groundbreaking development has emerged to potentially transform their lives. Opterion Health AG, a clinical-stage biopharmaceutical company
